Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-15-059061
Filing Date
2015-10-13
Accepted
2015-10-13 08:45:26
Documents
2
Period of Report
2015-10-13

Document Format Files

Seq Description Document Type Size
1 FORM 6-K v422012_6-k.htm 6-K 25766
2 GRAPHIC logo.jpg GRAPHIC 3938
  Complete submission text file 0001144204-15-059061.txt   32333
Mailing Address 85 MEDINAT HAYEHUDIM ST. PITUACH, PO BOX 4033 HERZLIYA L3 46140
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-36000 | Film No.: 151154704
SIC: 2834 Pharmaceutical Preparations